Literature DB >> 8298010

Microspectrofluorometry of the protonation state of ellipticine, an antitumor alkaloid, in single cells.

F Sureau1, F Moreau, J M Millot, M Manfait, B Allard, J Aubard, M A Schwaller.   

Abstract

The protonation state and intracellular distribution of ellipticine were investigated in single human mammary T47D cells by confocal laser microspectrofluorimetry. In the cell nucleus, only the protonated form of ellipticine was detected as a direct consequence of its apparent pK increase upon DNA binding. Both protonated and neutral forms were present in the aqueous cytoplasm, where the pH is close to the drug pK. When cells were incubated in high concentrations of K+, a condition that depolarizes the plasma membrane potential, ellipticine cellular accumulation was reduced. In the cytoplasm, ellipticine was mainly bound to mitochondria, and its protonation equilibrium was shifted toward the neutral form. The fluorescence spectrum of ellipticine bound to mitochondria was insensitive to valinomycin, whereas it was markedly shifted toward the protonated form after carbonyl cyanide p-trifluoromethoxy-phenylhydrazone or nigericin addition. Similar studies with ellipticine bound to isolated mitochondria suggest that it behaves as a fluorescent probe of mitochondrial pH in both isolated mitochondria and single living cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298010      PMCID: PMC1225912          DOI: 10.1016/S0006-3495(93)81273-6

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  31 in total

1.  Structural considerations in the interaction of DNA and acridines.

Authors:  L S LERMAN
Journal:  J Mol Biol       Date:  1961-02       Impact factor: 5.469

2.  A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.

Authors:  J B Le Pecq; C Gosse; C Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

3.  Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment.

Authors:  E Goormaghtigh; R Brasseur; J M Ruysschaert
Journal:  Biochem Biophys Res Commun       Date:  1982-01-15       Impact factor: 3.575

4.  Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells.

Authors:  S Davis; M J Weiss; J R Wong; T J Lampidis; L B Chen
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

5.  Effect of membrane potential on the cellular uptake of 2-N-methyl-ellipticinium by L1210 cells.

Authors:  J Y Charcosset; A Jacquemin-Sablon; J B Le Pecq
Journal:  Biochem Pharmacol       Date:  1984-07-15       Impact factor: 5.858

6.  Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiae.

Authors:  M Pinto; M Guerineau; C Paoletti
Journal:  Biochem Pharmacol       Date:  1982-06-15       Impact factor: 5.858

7.  Uptake and cytofluorescence localization of ellipticine derivatives in sensitive and resistant Chinese hamster lung cells.

Authors:  J Y Charcosset; B Salles; A Jacquemin-Sablon
Journal:  Biochem Pharmacol       Date:  1983-03-15       Impact factor: 5.858

8.  Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells.

Authors:  A K Larsen; J Paoletti; J Belehradek; C Paoletti
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

9.  Membrane potential and surface potential in mitochondria: uptake and binding of lipophilic cations.

Authors:  H Rottenberg
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

10.  Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy.

Authors:  L V Johnson; M L Walsh; B J Bockus; L B Chen
Journal:  J Cell Biol       Date:  1981-03       Impact factor: 10.539

View more
  8 in total

1.  Fluorescent cationic probes for nuclei of living cells: why are they selective? A quantitative structure-activity relations analysis.

Authors:  Richard W Horobin; Juan C Stockert; Fiza Rashid-Doubell
Journal:  Histochem Cell Biol       Date:  2006-02-07       Impact factor: 4.304

2.  The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells.

Authors:  G Bkaily; P Pothier; P D'Orléans-Juste; M Simaan; D Jacques; D Jaalouk; F Belzile; G Hassan; C Boutin; G Haddad; W Neugebauer
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 3.  Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies.

Authors:  Ahmed A Heikal
Journal:  Biomark Med       Date:  2010-04       Impact factor: 2.851

4.  A role for mitochondria in the establishment and maintenance of the maize root quiescent center.

Authors:  Keni Jiang; Tracy Ballinger; Daisy Li; Shibo Zhang; Lewis Feldman
Journal:  Plant Physiol       Date:  2006-01-27       Impact factor: 8.340

5.  The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.

Authors:  Jing-Ping Wang; Ya-Chu Yu; Shih-Ping Chen; Huan-Chang Liang; Chia-Wei Lin; Kang Fang
Journal:  Mol Cell Biochem       Date:  2015-05-27       Impact factor: 3.396

6.  Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cells.

Authors:  E G Russell; E C O'Sullivan; C M Miller; J Stanicka; F O McCarthy; T G Cotter
Journal:  Invest New Drugs       Date:  2014-08-10       Impact factor: 3.850

7.  Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line.

Authors:  L Miccoli; S Oudard; F Sureau; F Poirson; B Dutrillaux; M F Poupon
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

8.  Pharmacokinetics of peptide mediated delivery of anticancer drug ellipticine.

Authors:  Weina Ma; Sheng Lu; Pei Pan; Parisa Sadatmousavi; Yongfang Yuan; P Chen
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.